Skip to content
synovial sarcoma foundation
  • About
    • Mission
    • Initiatives
    • Affiliations
    • Leadership
    • Board of Directors
    • Careers
  • Resources
    • Synovial Sarcoma FAQ
    • Treatments
    • Clinical Trials & Therapies
    • Synovial Sarcoma Patient Survey
    • Synovial Sarcoma Tumor Board
    • Patient Stories
  • Research Programs
    • Clinical Research
    • Tumor Glow
    • Synovial Sarcoma Registry
  • Latest News
Donate

Send us a note

Please fill out the form below and we will gladly respond as soon as possible.

Edit Content

    National Tumor Board

    • Home
    • National Tumor Board
    A modern, multi-story medical research center is illuminated at dusk, with large glass windows and well-lit interiors. The building is labeled “Houston Methodist Research Institute.” City lights are visible in the background.
    Tumor Board, Research

    Tumor Board Continues to Grow with New Members to Advance Breakthrough Treatments for Synovial Sarcoma Patients

    July 22, 2025 joshs Comments Off on Tumor Board Continues to Grow with New Members to Advance Breakthrough Treatments for Synovial Sarcoma Patients

    We are proud to share that the Tumor Board now includes 42 participating institutions, strengthening our collective expertise and reach. These new members, along with our existing institutions, greatly enhance our ability to develop and implement cutting-edge, individualized treatment plans.

    Search

    Categories

    • Black Flag Racing (2)
    • Children (1)
    • CHOP (3)
    • Development (4)
    • Dr. Theodore Laetsch (3)
    • Education (6)
    • Healthcare (5)
    • Latest News (7)
    • Rare Cancer (1)
    • Research (15)
    • Synovial Sarcoma Conference (2)
    • Synovial Sarcoma Registry (3)
    • Teresa Belluco (1)
    • Tumor Board (2)

    Recent posts

    • A wooden judge’s gavel with a gold band rests on top of a British flag, symbolizing law or justice in the United Kingdom.
      A Turning Point for Rare Cancers
    • A scientist wearing safety glasses and gloves closely examines samples through a microscope in a laboratory setting, concentrating on her research.
      Afamitresgene Autoleucel (Afami-cel): T-Cell Therapy Shows Promise in Synovial Sarcoma
    • A virtual meeting with five professionals, three men and two women, each in their own space, looking at their cameras. Names and titles are displayed for some participants at the bottom of their video frames.
      Synovial Sarcoma Foundation Hosts Second Community Webinar Highlighting Research Momentum

    Tags

    Afami-cel Black Flag Racing Brigham and Women’s Hospital Callan Spence cancer-testis antigen Cancer Research Chase Spence Chas Spence CHOP Clinical Trials Dr. Rachel Hurly Dr. Ted Laetsch fibroblast fibroblast epigenome ground breaking human cell therapy immune-cell therapy Infant JAMA Internal Medicine Julie Kramer MAGE-A4 Market Growth Monophasic Synovial Sarcoma National Tumor Board Nature Communications P300 Parotid Gland Patient Stories Pediatric Oncology Penn Medicine Prasterone Rare Cancer research Sarcoma Synovial Sarcoma Synovial Sarcoma Foundation synovial sarcoma survivor synovial sarcoma treatment T-Cell Therapy TCR-NK TECELRA UK’s Rare Cancers Bill webinar Zelluna ZI-MA4-1

    The Synovial Sarcoma Foundation is a registered 501(c)(3) nonprofit organization. Tax ID number is 33-4027591. Contributions to the Synovial Sarcoma Foundation are tax-deductible to the extent permitted by law.

    • Terms & conditions
    • Privacy policy
    synovial sarcoma foundation
    • community@synovialsarcoma.org
    Facebook-f X-twitter Linkedin

    Navigation

    • About
    • Research Programs
    • Patient Stories
    • Resources

    Stay in touch